Both Skyrizi and its cousin Rinvoq have landed in the annual top three, in varying positions, since 2022. That was once again the case in 2025, when Skyrizi retained its place at the top and Rinvoq ...
Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad spending rankings. Indeed, since September, they’d taken turns alternating between ...
Tremfya’s reign atop the TV pharma ad rankings continued for yet another month as the Johnson & Johnson brand topped iSpot.tv’s list for October. Tremyfa achieved an impressions share of voice (SOV) ...
Tremfya snagged Dupixent’s place as the pharma brand with the most TV impressions in June, according to data released by iSpot.tv on Friday morning. The Johnson & Johnson brand garnered a 4.3% share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback